Vestibulodynia: Clinical characteristics, first-line treatments, and factors associated with escalation of treatment with EMG-guided injections of botulinum toxin in a retrospective french cohort study.
Fiche publication
Date publication
avril 2024
Journal
Annales de dermatologie et de venereologie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr AUBIN François
Tous les auteurs :
Neuville C, Parratte B, Lombion S, Aubin F, Gallais Sérézal I, Pelletier F
Lien Pubmed
Résumé
Vestibulodynia is a highly prevalent chronic pain disorder affecting the vulva having a major impact on women's physical, psychological, and sexual well-being. It remains an underrecognized disease that responds insufficiently to therapies such as physiotherapy and medication.
Mots clés
Vestibulodynia, Women's health, botulinum toxin type A
Référence
Ann Dermatol Venereol. 2024 04 27;151(2):103277